Scholarly Index
Alessandro Biffi
Eli Lilly (United States); 20,745 total citations; 232 total publications; best world rank #64
Eli Lilly (United States)
20,745Total citations
232Total publications
62H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 122 | US 54 | 98.89 |
| Acute Ischemic Stroke Management | Lifetime | 583 | US 229 | 98.38 |
| Cardiovascular Effects of Exercise | Lifetime | 489 | US 216 | 97.31 |
| Neurosurgical Procedures and Complications | Lifetime | 307 | US 158 | 97.18 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 932 | US 368 | 91.64 |
| Cerebrovascular and genetic disorders | Lifetime | 388 | US 98 | 87.25 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 64 | US 30 | 97.07 |
| Acute Ischemic Stroke Management | 2021-2025 | 769 | US 227 | 94.61 |
| Neurosurgical Procedures and Complications | 2021-2025 | 382 | US 161 | 85.17 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 632 | US 205 | 81.67 |
| Cerebrovascular and genetic disorders | 2021-2025 | 399 | US 63 | 54.21 |